| Neoequigel |
|
|
|
|
Description: Composition: Dosage form: Gel. Route of administration: Topical. |
| < Prev | Next > |
|---|
UNIQUE INNOVATIONS
Other Links...
You are here :Home
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.
Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.
